Bausch Financial Statements From 2010 to 2024
| BVF Stock | EUR 7.63 0.20 2.69% |
Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
Bausch |
Bausch Health Companies Company Operating Margin Analysis
Bausch Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bausch Health Operating Margin | 0.18 % |
Most of Bausch Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bausch Health Companies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bausch Health Companies has an Operating Margin of 0.1827%. This is 100.52% lower than that of the Healthcare sector and 100.5% lower than that of the Drug Manufacturers - Specialty & Generic industry. The operating margin for all Germany stocks is 103.32% lower than that of the firm.
Bausch Health Companies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bausch Health's current stock value. Our valuation model uses many indicators to compare Bausch Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bausch Health competition to find correlations between indicators driving Bausch Health's intrinsic value. More Info.Bausch Health Companies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bausch Health's earnings, one of the primary drivers of an investment's value.About Bausch Health Financial Statements
Bausch Health stakeholders use historical fundamental indicators, such as Bausch Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bausch Health's assets and liabilities are reflected in the revenues and expenses on Bausch Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bausch Health Companies. Please read more on our technical analysis and fundamental analysis pages.
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. BAUSCH HEALTH operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21100 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Bausch Stock
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out the analysis of Bausch Health Correlation against competitors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.